Reduction of SIRT1 epigenetically upregulates NALP1 expression and contributes to neuropathic pain induced by chemotherapeutic drug bortezomib

BACKGROUND: Bortezomib is a frequently used chemotherapeutic drug for the treatment of multiple myeloma and other nonsolid malignancies. Accumulating evidence has demonstrated that bortezomib-induced persistent pain serves as the most frequent reason for treatment discontinuation. METHODS: The von F...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kun, Fan, Jing, Luo, Zhao-Fan, Yang, Ying, Xin, Wen-Jun, Liu, Cui-Cui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195754/
https://www.ncbi.nlm.nih.gov/pubmed/30342528
http://dx.doi.org/10.1186/s12974-018-1327-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6195754/
https://www.ncbi.nlm.nih.gov/pubmed/30342528
http://dx.doi.org/10.1186/s12974-018-1327-x

Ejemplares similares